These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23616666)

  • 1. Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.
    Turk G; Ghiglione Y; Falivene J; Socias ME; Laufer N; Coloccini RS; Rodriguez AM; Ruiz MJ; Pando MÁ; Giavedoni LD; Cahn P; Sued O; Salomon H; Gherardi MM
    J Virol; 2013 Jul; 87(13):7445-62. PubMed ID: 23616666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype, Polyfunctionality, and Antiviral Activity of
    Salido J; Ruiz MJ; Trifone C; Figueroa MI; Caruso MP; Gherardi MM; Sued O; Salomón H; Laufer N; Ghiglione Y; Turk G
    Front Immunol; 2018; 9():2443. PubMed ID: 30405632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
    Pettersen FO; Taskén K; Kvale D
    Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection.
    Eller MA; Eller LA; Ratto-Kim S; Ouma BJ; Lo V; de Souza M; Guwatudde D; Nails B; Michael NL; Wabwire-Mangen F; Robb ML; Marovich MA; Sandberg JK; Currier JR
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):9-18. PubMed ID: 22580564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses.
    Julg B; Williams KL; Reddy S; Bishop K; Qi Y; Carrington M; Goulder PJ; Ndung'u T; Walker BD
    J Virol; 2010 Jun; 84(11):5540-9. PubMed ID: 20335261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Immunodominance Hierarchy of CD8
    Adland E; Hill M; Lavandier N; Csala A; Edwards A; Chen F; Radkowski M; Kowalska JD; Paraskevis D; Hatzakis A; Valenzuela-Ponce H; Pfafferott K; Williams I; Pellegrino P; Borrow P; Mori M; Rockstroh J; Prado JG; Mothe B; Dalmau J; Martinez-Picado J; Tudor-Williams G; Frater J; Stryhn A; Buus S; Teran GR; Mallal S; John M; Buchbinder S; Kirk G; Martin J; Michael N; Fellay J; Deeks S; Walker B; Avila-Rios S; Cole D; Brander C; Carrington M; Goulder P
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.
    López M; Peris A; Soriano V; Lozano S; Vicario JL; Rallón NI; Restrepo C; Benito JM
    Immunology; 2011 Nov; 134(3):305-13. PubMed ID: 21978000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
    Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection.
    Riou C; Ganusov VV; Campion S; Mlotshwa M; Liu MK; Whale VE; Goonetilleke N; Borrow P; Ferrari G; Betts MR; Haynes BF; McMichael AJ; Gray CM
    J Immunol; 2012 Mar; 188(5):2198-206. PubMed ID: 22287716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells.
    Huang XL; Fan Z; Borowski L; Rinaldo CR
    Clin Vaccine Immunol; 2009 Oct; 16(10):1504-16. PubMed ID: 19692626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment.
    Huang S; Dunkley-Thompson J; Tang Y; Macklin EA; Steel-Duncan J; Singh-Minott I; Ryland EG; Smikle M; Walker BD; Christie CD; Feeney ME
    J Immunol; 2008 Dec; 181(11):8103-11. PubMed ID: 19018003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyfunctional analysis of Gag and Nef specific CD8+ T-cell responses in HIV-1 infected Indian individuals.
    Mendiratta S; Vajpayee M; Mojumdar K; Chauhan NK; Sreenivas V
    Vaccine; 2011 Feb; 29(6):1150-8. PubMed ID: 21172377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Immunogen Selectively Eliciting CD8
    Ishii H; Terahara K; Nomura T; Takeda A; Okazaki M; Yamamoto H; Tokusumi T; Shu T; Matano T
    J Virol; 2020 Mar; 94(8):. PubMed ID: 32024773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection.
    Radebe M; Gounder K; Mokgoro M; Ndhlovu ZM; Mncube Z; Mkhize L; van der Stok M; Jaggernath M; Walker BD; Ndung'u T
    AIDS; 2015 Jan; 29(1):23-33. PubMed ID: 25387316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents.
    Sharp ER; Willberg CB; Kuebler PJ; Abadi J; Fennelly GJ; Dobroszycki J; Wiznia AA; Rosenberg MG; Nixon DF
    PLoS One; 2011; 6(7):e21135. PubMed ID: 21818255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.
    Niu L; Termini JM; Kanagavelu SK; Gupta S; Rolland MM; Kulkarni V; Pavlakis GN; Felber BK; Mullins JI; Fischl MA; Stone GW
    Vaccine; 2011 Mar; 29(11):2110-9. PubMed ID: 21241732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants.
    Thobakgale CF; Ramduth D; Reddy S; Mkhwanazi N; de Pierres C; Moodley E; Mphatswe W; Blanckenberg N; Cengimbo A; Prendergast A; Tudor-Williams G; Dong K; Jeena P; Kindra G; Bobat R; Coovadia H; Kiepiela P; Walker BD; Goulder PJ
    J Virol; 2007 Dec; 81(23):12775-84. PubMed ID: 17881456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.